Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis

BACKGROUND: The effects of metformin (MET) and curcumin (CUR) single treatments have been tested against breast cancer; however, their combination has not been explored. Here, we evaluated the antitumor activity of MET and CUR combination against breast cancer in mice. MATERIALS AND METHODS: The ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Falah, Rabah Rashad, Talib, Wamidh H., Shbailat, Seba Jamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405996/
https://www.ncbi.nlm.nih.gov/pubmed/28491145
http://dx.doi.org/10.1177/1758834016687482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405996/
https://www.ncbi.nlm.nih.gov/pubmed/28491145
http://dx.doi.org/10.1177/1758834016687482

Ejemplares similares